Browse > Article
http://dx.doi.org/10.3904/kjm.2012.82.1.60

Clinical and Histopathological Study of Pheochromocytoma Arising in the Adrenal Gland  

Hong, Suk-Ho (Department of Pathology, Chungnam National University School of Medicine and Cancer Research Institute)
Kang, Gu-Hyum (Department of Internal Medicine, Graduate School of Chungnam National University)
Kang, Dae-Young (Department of Pathology, Chungnam National University School of Medicine and Cancer Research Institute)
Publication Information
The Korean Journal of Medicine / v.82, no.1, 2012 , pp. 60-66 More about this Journal
Abstract
Background/Aims: The diagnosis and prognosis of malignant pheochromocytoma are important. Other than distant metastasis, the pathology is insufficient to diagnose malignant versus benign pheochromocytoma. Methods: We analyzed 33 pheochromocytoma cases using the histological grade on the Thompson and Kimura scales. We compared the Thompson and Kimura scores with the degree of immunohistochemical staining for Ki-67 and heat shock protein 90 (Hsp90). Results: The most frequent symptom was hypertension (17 cases; 51.5%) and four patients had accompanying tumors: one case each of multiple endocrine neoplasm, papillary carcinoma of the thyroid, gastric adenocarcinoma, and neurofibroma. The mean Thompson score was 3.67 in benign pheochromocytoma and 10 in malignant pheochromocytoma, and the Kimura score was 2.17 and 5, respectively. The average immunohistochemical staining for Ki-67 was 5.77 and 10.44 in benign and malignant pheochromocytoma, respectively, while Hsp90 immunohistochemical staining was positive only in the cytoplasm of malignant pheochromocytoma. Conclusions: Immunohistochemical staining for Ki-67 and Hsp90 was seen in malignant pheochromocytoma. The Thompson and Kimura scales and immunohistochemical results could help to differentiate benign and malignant pheochromocytoma.
Keywords
Pheochromocytoma; Ki-67 antigen; HSP90; Heat-shock protein;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-1466.   DOI
2 DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon: IARC Press, 2004.
3 Lai EW, Perera SM, Havekes B, et al. Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma. Endocrine 2008;34:96-100.   DOI
4 Kim HY, Kim SG, Lee KW, et al. Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 2005;20:303-309.   DOI
5 Gao B, Kong F, Xu Z. Development of differential diagnosis for benign and malignant pheochromocytomas. Int J Urol 2008;15:771-777.   DOI
6 Strong VE, Kennedy T, Al-Ahmadie H, et al. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery 2008;143:759-768.   DOI
7 Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 2002;26:551-566.   DOI
8 Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extraadrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 2005;16:23-32.   DOI
9 Ahn SK, Ahn KJ, Lee EJ, et al. Clinical review of pheochromocytoma. J Korean Soc Endocrinol 1991;6:245-253.
10 Noshiro T, Shimizu K, Watanabe T, et al. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. Am J Hypertens 2000;13:35-43.   DOI
11 Shin DH, Kim SG, Kim DR, et al. Clinical study of the pheochromocytoma. J Korean Soc Endocrinol 2002;17: 554-563.
12 Wu D, Tischler AS, Lloyd RV, et al. Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. Am J Surg Pathol 2009;33:599-608.   DOI
13 Tischler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med 2008;132:1272-1284.
14 Kumar V, Abbas AK, Fausto N, Aster JC. Pathologic Basis of Disease. 8th ed. Philadelphia: Saunders-Elsevier, 2010.
15 Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K. Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 1998;82:176-179.   DOI
16 Scholz T, Schulz C, Klose S, Lehnert H. Diagnostic management of benign and malignant pheochromocytoma. ExpClin Endocrinol Diabetes 2007;115:155-159.